VANCOUVER, BRITISH COLUMBIA--(Marketwired - Mar 20, 2017) - SOLARVEST BIOENERGY INC. (TSX VENTURE:SVS)
("Solarvest" or the "Company") announces it has obtained a 30 day extension from the TSX Venture Exchange in order to complete
its previously announced private placement financing with Drashta Ventures, a United Kingdom based impact investment fund
("Drashta").
As previously announced Solarvest, has already closed a first tranche of Cdn$250,000 of the anticipated Cdn$1,000,000
placement of an aggregate 4,000,000 units at a price of $0.25 per unit. Each unit consists of one common share and one whole
warrant. Each whole warrant entitles the holder to acquire one additional common share of the Company at a price of $0.35 per
share for a period of two years following closing and includes an acceleration clause that is triggered by a 20 day volume
weighted average price greater than $0.95 per share.
The balance of the financing may close in two or more tranches. All securities issued pursuant to this tranche are subject to
resale restrictions for a period of four months and one day from closing under applicable securities legislation, and final
approval by the TSX Venture Exchange.
About Drashta:
Drashta Ventures' is an innovative impact investment fund sponsored by Drashta Capital whose mission is to harness the
collective power of capital, technology and people to solve the most pressing challenges facing the world today. With the 17
Sustainable Development Goals defined by the UN as its initial guide, Drashta invests in early and mid-stage companies that have
a strong social or environmental impact, while protecting investors' interests under a unique, self-sustaining capital protection
model.
About Solarvest:
Solarvest BioEnergy Inc. is an algae technology company whose algal-based production platform provides it with an
extremely flexible system capable of being adapted to produce clean energy in the form of hydrogen and health products such as
omega oils in an economic and environmentally sensitive manner.
The TSX Venture Exchange has neither approved nor disapproved the contents of this news release. Neither
TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
The statements made in this news release may contain forward-looking statements that may involve a number
of risks and uncertainties. Actual events or results could differ materially from the Company's expectations and
projections.